D09.9
Billable codeCarcinoma in situ, unspecified
The ICD-10 code for carcinoma in situ, unspecified is D09.9.
Documentation support
General coding-documentation guidance — not a substitute for payer-specific requirements or professional coding judgment.
- •This code describes an unspecified presentation. If the medical record documents a more specific detail (e.g. laterality, type, or affected site), a more specific sibling code should be used instead — see Related codes below.
- •As a general rule, code to the highest level of specificity supported by the documentation in the medical record.
Related codes in this category
- D09.0Carcinoma in situ of bladder
- D09.1Carcinoma in situ of other and unspecified urinary organsnon-billable header
- D09.2Carcinoma in situ of eyenon-billable header
- D09.3Carcinoma in situ of thyroid and other endocrine glands
- D09.8Carcinoma in situ of other specified sites
- D09.9Carcinoma in situ, unspecified
ICD-9-CM equivalent
Informational only — GEM mappings are approximate, not guaranteed one-to-one equivalents. Verify before use in billing.
- 2349
Associated MS-DRGs
D09.9 can serve as the principal diagnosis for these Medicare Severity Diagnosis-Related Groups.
Informational only — actual DRG assignment also depends on procedures, complications/comorbidities (CC/MCC), discharge status, and payer-specific rules not reflected here.
- DRG 814Reticuloendothelial and Immunity Disorders with MCC
- DRG 815Reticuloendothelial and Immunity Disorders with CC
- DRG 816Reticuloendothelial and Immunity Disorders without CC/MCC
- DRG 826Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with MCC
- DRG 827Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with CC
- DRG 828Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures without CC/MCC
- DRG 829Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures with CC/MCC
- DRG 830Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures without CC/MCC
- DRG 843Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses with MCC
- DRG 844Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses with CC
- DRG 845Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses without CC/MCC